Alcohol Use Disorder Associated Gene FNDC4 Alters Glutamatergic and GABAergic Neurogenesis.

Saved in:
Bibliographic Details
Title: Alcohol Use Disorder Associated Gene FNDC4 Alters Glutamatergic and GABAergic Neurogenesis.
Authors: Zhu X; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN. U.S.A., John AJ; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN. U.S.A., Wang L; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN. U.S.A., Kim S; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN. U.S.A., Ding E; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN. U.S.A., Saleh A; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN. U.S.A., Marín-Goñi I; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN. U.S.A., Jomaa A; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN. U.S.A., Gao H; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN. U.S.A., Wai CM; Department of Biochemistry and Molecular Genetics, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA., Moon I; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN. U.S.A., Coombes BJ; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, U.S.A., Kerr TM; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN. U.S.A., Suto N; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN. U.S.A., Wang L; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN. U.S.A., Frye MA; Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, U.S.A., Biernacka JM; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, U.S.A.; Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, U.S.A., Karpyak VM; Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, U.S.A., Li H; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN. U.S.A., Weinshilboum RM; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN. U.S.A., Liu D; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN. U.S.A.
Source: BioRxiv : the preprint server for biology [bioRxiv] 2025 May 16. Date of Electronic Publication: 2025 May 16.
Publication Type: Journal Article; Preprint
Journal Info: Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40463052
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Alcohol Use Disorder Associated Gene FNDC4 Alters Glutamatergic and GABAergic Neurogenesis.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Zhu+X%22">Zhu X</searchLink>; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN. U.S.A.<br /><searchLink fieldCode="AU" term="%22John+AJ%22">John AJ</searchLink>; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN. U.S.A.<br /><searchLink fieldCode="AU" term="%22Wang+L%22">Wang L</searchLink>; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN. U.S.A.<br /><searchLink fieldCode="AU" term="%22Kim+S%22">Kim S</searchLink>; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN. U.S.A.<br /><searchLink fieldCode="AU" term="%22Ding+E%22">Ding E</searchLink>; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN. U.S.A.<br /><searchLink fieldCode="AU" term="%22Saleh+A%22">Saleh A</searchLink>; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN. U.S.A.<br /><searchLink fieldCode="AU" term="%22Marín-Goñi+I%22">Marín-Goñi I</searchLink>; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN. U.S.A.<br /><searchLink fieldCode="AU" term="%22Jomaa+A%22">Jomaa A</searchLink>; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN. U.S.A.<br /><searchLink fieldCode="AU" term="%22Gao+H%22">Gao H</searchLink>; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN. U.S.A.<br /><searchLink fieldCode="AU" term="%22Wai+CM%22">Wai CM</searchLink>; Department of Biochemistry and Molecular Genetics, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.<br /><searchLink fieldCode="AU" term="%22Moon+I%22">Moon I</searchLink>; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN. U.S.A.<br /><searchLink fieldCode="AU" term="%22Coombes+BJ%22">Coombes BJ</searchLink>; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, U.S.A.<br /><searchLink fieldCode="AU" term="%22Kerr+TM%22">Kerr TM</searchLink>; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN. U.S.A.<br /><searchLink fieldCode="AU" term="%22Suto+N%22">Suto N</searchLink>; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN. U.S.A.<br /><searchLink fieldCode="AU" term="%22Wang+L%22">Wang L</searchLink>; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN. U.S.A.<br /><searchLink fieldCode="AU" term="%22Frye+MA%22">Frye MA</searchLink>; Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, U.S.A.<br /><searchLink fieldCode="AU" term="%22Biernacka+JM%22">Biernacka JM</searchLink>; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, U.S.A.; Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, U.S.A.<br /><searchLink fieldCode="AU" term="%22Karpyak+VM%22">Karpyak VM</searchLink>; Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, U.S.A.<br /><searchLink fieldCode="AU" term="%22Li+H%22">Li H</searchLink>; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN. U.S.A.<br /><searchLink fieldCode="AU" term="%22Weinshilboum+RM%22">Weinshilboum RM</searchLink>; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN. U.S.A.<br /><searchLink fieldCode="AU" term="%22Liu+D%22">Liu D</searchLink>; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN. U.S.A.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101680187%22">BioRxiv : the preprint server for biology</searchLink> [bioRxiv] 2025 May 16. <i>Date of Electronic Publication: </i>2025 May 16.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Preprint
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Country of Publication: </i>United States <i>NLM ID: </i>101680187 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2692-8205 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2226928205%22">26928205 </searchLink><i>NLM ISO Abbreviation: </i>bioRxiv <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40463052
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1101/2025.05.15.654319
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Alcohol Use Disorder Associated Gene FNDC4 Alters Glutamatergic and GABAergic Neurogenesis.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Zhu X
      – PersonEntity:
          Name:
            NameFull: John AJ
      – PersonEntity:
          Name:
            NameFull: Wang L
      – PersonEntity:
          Name:
            NameFull: Kim S
      – PersonEntity:
          Name:
            NameFull: Ding E
      – PersonEntity:
          Name:
            NameFull: Saleh A
      – PersonEntity:
          Name:
            NameFull: Marín-Goñi I
      – PersonEntity:
          Name:
            NameFull: Jomaa A
      – PersonEntity:
          Name:
            NameFull: Gao H
      – PersonEntity:
          Name:
            NameFull: Wai CM
      – PersonEntity:
          Name:
            NameFull: Moon I
      – PersonEntity:
          Name:
            NameFull: Coombes BJ
      – PersonEntity:
          Name:
            NameFull: Kerr TM
      – PersonEntity:
          Name:
            NameFull: Suto N
      – PersonEntity:
          Name:
            NameFull: Wang L
      – PersonEntity:
          Name:
            NameFull: Frye MA
      – PersonEntity:
          Name:
            NameFull: Biernacka JM
      – PersonEntity:
          Name:
            NameFull: Karpyak VM
      – PersonEntity:
          Name:
            NameFull: Li H
      – PersonEntity:
          Name:
            NameFull: Weinshilboum RM
      – PersonEntity:
          Name:
            NameFull: Liu D
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 16
              M: 05
              Text: 2025 May 16
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2692-8205
          Titles:
            – TitleFull: BioRxiv : the preprint server for biology
              Type: main
ResultId 1